Finzati - Logo
ATTO logo

Attovia Therapeutics, Inc.

ATTO • Biotechnology
$25.55
▲ +1.35 (+5.58%)
Current price
EarningsSep 4, 11:07 AM UTC
New financial eventQ2 2026Mixed

Attovia Therapeutics, Inc. has reported Q2 2026 financial results

The latest report contains a combination of positive and negative financial changes. The stronger areas should be weighed against the weaker ones before drawing conclusions. The report may attract increased investor attention and price volatility.

Finzati signal
Mixed development
Sep 4, 11:07 AM UTC
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Sep 4, 2026, 11:07 AM UTCLast profile update: Sep 4, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$25.55
Change5.58%
Shares Out43.03M
Market Cap$1.10B
Enterprise Value$986.32M
52W Range16.15 - 26.07
Beta0.00
P/B9.75
Gross Margin40.44%
Oper. Margin-49.75%
Profit Margin-44.91%
Debt/Eq0.03

Investment DNA

How strong this company looks for long-term investors

27
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
36/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 14.2Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-04
Low
$39.00
Mean
$45.33
Median
$45.00
High
$52.00

Company Overview

IPO: 8/5/2026
Industry: Biotechnology
P/B i: 9.75
Debt / Equity i: 0.03
Operating Margin: -4974.74%
Net Margin: -4490.89%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 14.20
Quick Ratio: 14.20
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 10 high-volume insider sells detected
GOLDMAN SACHS GROUP INC
Transaction: 08/05/2026
BUY
Change
+2,872
Price
Not reported
Filing
08/28/2026
Type
BUY
WALSH COLIN
Transaction: 08/05/2026
BUY
Change
+2,872
Price
Not reported
Filing
08/28/2026
Type
BUY
GOLDMAN SACHS GROUP INC
Transaction: 08/06/2026
SELL
Change
-4,445,275
Price
Not reported
Filing
08/13/2026
Type
SELL